Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

121 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action.
Lecour S, Andreadou I, Bøtker HE, Davidson SM, Heusch G, Ruiz-Meana M, Schulz R, Zuurbier CJ, Ferdinandy P, Hausenloy DJ; on behalf of the European Union-CARDIOPROTECTION COST ACTION CA16225. Lecour S, et al. Among authors: zuurbier cj. Basic Res Cardiol. 2021 Sep 13;116(1):52. doi: 10.1007/s00395-021-00893-5. Basic Res Cardiol. 2021. PMID: 34515837 Free PMC article. Review.
Innate immunity as a target for acute cardioprotection.
Zuurbier CJ, Abbate A, Cabrera-Fuentes HA, Cohen MV, Collino M, De Kleijn DPV, Downey JM, Pagliaro P, Preissner KT, Takahashi M, Davidson SM. Zuurbier CJ, et al. Cardiovasc Res. 2019 Jun 1;115(7):1131-1142. doi: 10.1093/cvr/cvy304. Cardiovasc Res. 2019. PMID: 30576455 Free PMC article. Review.
NLRP3 Inflammasome in Cardioprotective Signaling.
Zuurbier CJ. Zuurbier CJ. J Cardiovasc Pharmacol. 2019 Oct;74(4):271-275. doi: 10.1097/FJC.0000000000000696. J Cardiovasc Pharmacol. 2019. PMID: 31356546 Review.
Effect of hyperglycaemia and diabetes on acute myocardial ischaemia-reperfusion injury and cardioprotection by ischaemic conditioning protocols.
Penna C, Andreadou I, Aragno M, Beauloye C, Bertrand L, Lazou A, Falcão-Pires I, Bell R, Zuurbier CJ, Pagliaro P, Hausenloy DJ. Penna C, et al. Among authors: zuurbier cj. Br J Pharmacol. 2020 Dec;177(23):5312-5335. doi: 10.1111/bph.14993. Epub 2020 Mar 9. Br J Pharmacol. 2020. PMID: 31985828 Free PMC article. Review.
Chronic Empagliflozin Treatment Reduces Myocardial Infarct Size in Nondiabetic Mice Through STAT-3-Mediated Protection on Microvascular Endothelial Cells and Reduction of Oxidative Stress.
Nikolaou PE, Efentakis P, Abu Qourah F, Femminò S, Makridakis M, Kanaki Z, Varela A, Tsoumani M, Davos CH, Dimitriou CA, Tasouli A, Dimitriadis G, Kostomitsopoulos N, Zuurbier CJ, Vlahou A, Klinakis A, Brizzi MF, Iliodromitis EK, Andreadou I. Nikolaou PE, et al. Among authors: zuurbier cj. Antioxid Redox Signal. 2021 Mar 1;34(7):551-571. doi: 10.1089/ars.2019.7923. Epub 2021 Jan 27. Antioxid Redox Signal. 2021. PMID: 32295413
Cardiac metabolism as a driver and therapeutic target of myocardial infarction.
Zuurbier CJ, Bertrand L, Beauloye CR, Andreadou I, Ruiz-Meana M, Jespersen NR, Kula-Alwar D, Prag HA, Eric Botker H, Dambrova M, Montessuit C, Kaambre T, Liepinsh E, Brookes PS, Krieg T. Zuurbier CJ, et al. J Cell Mol Med. 2020 Jun;24(11):5937-5954. doi: 10.1111/jcmm.15180. Epub 2020 May 8. J Cell Mol Med. 2020. PMID: 32384583 Free PMC article. Review.
121 results